SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Antonio Martin-Morales, Pedro Gutiérrez-Hernández, Javier Romero-Otero, José A. Romero-Martín, Duration of Erection: Does It Really Matter? A Randomized, Double-Blind Clinical Trial to Assess the Impact of Vardenafil ODT on Duration of Erection and Its Correlation with Patients' and Partners' Sexual Quality of Life and Duration of Intercourse: The VADEOPEN Study, The Journal of Sexual Medicine, 2014, 11, 6
  2. 2
    Pietro Gareri, Alberto Castagna, Davide Francomano, Gregorio Cerminara, Pasquale De Fazio, Erectile Dysfunction in the Elderly: An Old Widespread Issue with Novel Treatment Perspectives, International Journal of Endocrinology, 2014, 2014, 1

    CrossRef

  3. 3
    Roberto Bruzziches, Davide Francomano, Pietro Gareri, Andrea Lenzi, Antonio Aversa, An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors, Expert Opinion on Pharmacotherapy, 2013, 14, 10, 1333

    CrossRef

  4. 4
    Emmanuele A. Jannini, Leonard R. DeRogatis, Eric Chung, Gerald B. Brock, How to Evaluate the Efficacy of the Phosphodiesterase Type 5 Inhibitors, The Journal of Sexual Medicine, 2012, 9, 1
  5. 5
    Davide Arcaniolo, Ciro Imbimbo, Marco Grillo, Ferdinando Fusco, Vardenafil for the treatment of erectile dysfunction, Clinical Practice, 2012, 9, 1, 39

    CrossRef

  6. 6
    Mark Sanford, Vardenafil Orodispersible Tablet, Drugs, 2012, 72, 1, 87

    CrossRef

  7. 7
    Eric Chung, Gerald B Brock, A state of art review on vardenafil in men with erectile dysfunction and associated underlying diseases, Expert Opinion on Pharmacotherapy, 2011, 12, 8, 1341

    CrossRef

  8. 8
    Herbert Sperling, Marc Gittelman, Christiane Norenberg, Ernst Ulbrich, Silke Ewald, Efficacy and Safety of an Orodispersible Vardenafil Formulation for the Treatment of Erectile Dysfunction in Elderly Men and Those with Underlying Conditions: An Integrated Analysis of Two Pivotal Trials, The Journal of Sexual Medicine, 2011, 8, 1
  9. 9
    Pedro Ramón Gutiérrez Hernández, Nueva formulación bucodispersable de vardenafilo para el tratamiento de la disfunción eréctil, Revista Internacional de Andrología, 2011, 9, 1, 21

    CrossRef

  10. 10
    Roland Heinig, Boris Weimann, Hartmut Dietrich, Michael-Friedrich Böttcher, Pharmacokinetics of a New Orodispersible Tablet Formulation of Vardenafil, Clinical Drug Investigation, 2011, 31, 1, 27

    CrossRef

  11. 11
    Konstantinos Hatzimouratidis, Re: Efficacy and Safety of an Orodispersible Vardenafil Formulation for the Treatment of Erectile Dysfunction in Elderly Men and Those With Underlying Conditions: An Integrated Analysis of Two Pivotal Trials, European Urology, 2011, 59, 5, 880

    CrossRef

  12. 12
    Frans M.J. Debruyne, Marc Gittelman, Herbert Sperling, Matthias Börner, Manfred Beneke, Time to Onset of Action of Vardenafil: A Retrospective Analysis of the Pivotal Trials for the Orodispersible and Film-Coated Tablet Formulations, The Journal of Sexual Medicine, 2011, 8, 10
  13. 13
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2010, 19, 11